Lipotox

NDC

43857-0636

Route

Oral

Therapeutic class

Acidifying Activity [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone , Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Ammonium Ion Binding Activity [MoA], Anti-coagulant , Calcium Chelating Activity [MoA], Calculi Dissolution Agent , Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor , Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid , Decreased Coagulation Factor Activity [PE], Decreased Copper Ion Absorption [PE], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen , Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent , Nitrogen Binding Agent , Non-Standardized Plant Allergenic Extract , Pediculicide , Plant Proteins [CS], Progesterone [CS], Progesterone , Seed Storage Proteins [CS], Standardized Chemical Allergen , Standardized Chemical Allergen , Standardized Chemical Allergen

Marketing category

UNAPPROVED HOMEOPATHIC